Company / Free Cash Flow per Share
Cytokinetics Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$4452.98
FY2025
5-year range
-$4452.98 / -$2.26
FY2021-FY2025
Trend
-113105.6%
vs FY2024
Sector context
#192 of 192
Health Care
What the data says
Free Cash Flow per Share changed -113106% YoY in FY2025, a notable deviation from the 9-year average annual change of -13431%.
Based on SEC 10-K filings.
-4452.98 in FY2025.
Declined from $-4.38 to $-4452.98 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 192This company -$4452.98 Sector average -$19.84
▼
-22345.0% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 113105.6% year-over-year.
- Ranks #192 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4452.98 | -113105.6% |
| FY2024 | -$3.93 | +10.3% |
| FY2023 | -$4.38 | -19.6% |
| FY2022 | -$3.67 | -62.4% |
| FY2021 | -$2.26 | -7499.9% |
| FY2020 | -$0.03 | +98.1% |
| FY2019 | -$1.58 | +15.3% |
| FY2018 | -$1.87 | +3.8% |
| FY2017 | -$1.94 | -322.7% |
| FY2016 | $0.87 | +697.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026